Donald J. Hayden Jr.

Donald J. Hayden Jr. discloses dealings in Theseus Pharmaceuticals, Inc. to SEC (Form 4). The record holds 2 filings, for trades running from 29 December 2022 to 14 February 2024.

Purchases make up the whole of the open-market record (1 purchase, €470). Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.

Most recently, on 14 February 2024, the filings show a transaction in Theseus Pharmaceuticals, Inc. The last insider purchase was made public on 3 January 2023, 1,384 days ago. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.